Uncovering the risks of immunosuppressive therapy in patients with uveitis

Archives of Ophthalmology

Volumn 127, Issue 6, 2009, Pages 799-800

  Goldstein, Debra A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; INFLIXIMAB; PLACEBO; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR INHIBITOR;

CONGESTIVE HEART FAILURE; DRUG SAFETY; DRUG TOLERABILITY; EDITORIAL; EYE INFLAMMATION; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LUPUS LIKE SYNDROME; NEOPLASM; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SIDE EFFECT; THROMBOSIS; TREATMENT RESPONSE; UVEITIS; VEIN THROMBOSIS;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, MONOCLONAL; ARTHRITIS; CLINICAL TRIALS AS TOPIC; DNA; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; THROMBOSIS; TUMOR NECROSIS FACTOR-ALPHA; UVEITIS;

EID: 66949164033     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2009.124     Document Type: Editorial

References (14)

1. Tabbara KF, Al-Hemidan AI. Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease [published online ahead of print October 17, 2008]. Am J Ophthalmol. 2008;146(6):845-850, e1.
2. Kahn P, Weiss M, Imundo LF, Levy DM. Favorable response to high-dose infliximab for refractory childhood uveitis [published online ahead of print March 20, 2006]. Ophthalmology. 2006;113(5):860-864.e2.
3. Ardoin SP, Kredich D, Rabinovich E, Schanberg LE, Jaffe GJ. Infliximab to treat chronic noninfectious uveitis in children: retrospective case series with longterm follow-up [published online ahead of print October 22, 2007]. Am J Ophthalmol. 2007;144(6):844-849.
4. Sobrin L, Kim EC, Christen W, Papadaki T, Letko E, Foster CS. Infliximab therapy for the treatment of refractory ocular inflammatory disease. Arch Ophthalmol. 2007;125(7):895-900. (Pubitemid 47076425)
5. Tognon S, Graziani G, Marcolongo R. Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects. Ann N Y Acad Sci. 2007;1110:474-484. (Pubitemid 350043037)
6. Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA. 2006;295(19):2275-2285. (Pubitemid 43736578)
7. Ramos-Casals M, Brito-Zerón P, Muñoz S, et al. Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore). 2007;86(4):242-251. (Pubitemid 47067483)
8. Costa MF, Said NR, Zimmermann B. Drug-induced lupus due to anti-tumor necrosis factor alpha agents [published online ahead of print October 30, 2007]. Semin Arthritis Rheum. 2008;37(6):381-387.
9. Suhler EB, Smith JR, Giles TR, et al. Infliximab therapy for refractory uveitis: 2-year results of a prospective trial. Arch Ophthalmol. 2009;127(6):819-822.
10. Suhler EB, Smith JR, Wertheim MS, et al. A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes. Arch Ophthalmol. 2005;123(7):903-912. (Pubitemid 41057986)
11. Smitten AL, Simon TA, Hochberg MC, Suissa S. A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis [published online ahead of print April 23, 2008]. Arthritis Res Ther. 2008;10(2):R45.
12. De Bandt M, Sibilia J, Le Loët X, et al; Club Rhumatismes et Inflammation. Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey [published online ahead of print March 1, 2005]. Arthritis Res Ther. 2005;7(3):R545-R551.
13. Kempen JH, Daniel E, Gangaputra S, et al. Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study. Ophthalmic Epidemiol. 2008;15(1):47-55. (Pubitemid 351311499)
14. Okada AA. Noninfectious uveitis: a scarcity of randomized clinical trials. Arch Ophthalmol. 2005;123(5):682-683. (Pubitemid 40695517)